Incidence of Hyperphosphatemia and its Reduction Strategies in Children Undergoing Hemodialysis in Sheikh Mashhad Hospital in the First Month of the Year 97

Hemodialysis can have adverse effects, such as increased blood phosphorus in these patients. Considering the fact that hemodialysis does not affect the blood phosphorus in dialysis patients and in order to improve the quality of life in these patients, this study was conducted to determine the incidence of hyperphosphatemia and its reduction strategies in children undergoing hemodialysis.

This descriptive cross-sectional study was performed on 30 children undergoing hemodialysis in Sheikh's Children's Hospital in Mashhad. The incidence of hyperphosphatemia was measured by blood test of the patients. Data were collected using a questionnaire and analyzed by SPSS software.

In this study, 30 children were studied; 36.7% were girls and 63.3% were boys. 86.7% were hemodialysis for 3 sessions per week. The mean serum concentration of phosphorus in the first three months of the year was 6.8 mg / dl and the second quarter of 97 was 35 mg / dL.

According to the results of the second quarter of 1997, the mean serum concentration of phosphorus in children undergoing hemodialysis increased by 28.2 mg / dl compared to the same period of the first month of the year. This is while the calcium and phosphorus product, which is more important, has been reduced by 3.4 mg / dl after corrective action; therefore, this diet can be partially offset by increasing the amount of phosphorus in the blood.